Life Sciences NephroDI Therapeutics Lands Financing to Develop a Treatment for Nephrogenic Diabetes Insipidus, an… AIT News Desk May 13, 2021 Collaboration with Xontogeny provides funding and key advisory support for early development NephroDI Therapeutics, Inc., a biopharmaceutical…
Life Sciences Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally… AIT News Desk May 13, 2021 Collaboration with Xontogeny provides funding and key advisory support for early development Shifa Biomedical Corporation (Shifa), a drug discovery…
Life Sciences Nephraegis Therapeutics Launches with Seed Financing to Develop Small Molecules to Prevent and Treat… AIT News Desk May 13, 2021 Collaboration with Xontogeny provides funding and key advisory support for early development Nephraegis Therapeutics, Inc., a biopharmaceutical…
Life Sciences Perceptive Advisors Closes $515 Million Perceptive Xontogeny Venture Fund II, LP AIT News Desk May 13, 2021 PXV Fund II plans to lead Series A financings in 10 to 12 early-stage life sciences companies PXV Funds total $725 million of AUMs since…